Evidence map›Paper›PMID 29875239›Full record

ArticleJournal of virology2018

Mauricio A Martins, Damien C Tully, Núria Pedreño-Lopez, Benjamin von Bredow, Matthias G Pauthner, Young C Shin, Maoli Yuan, Noemia S Lima, David J Bean, Lucas Gonzalez-Nieto and 19 more

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of virology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Rhesus Cytomegalovirus-Specific CD8Frontiers in immunology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 9 institutions in 2 countries.

Mauricio A MartinsDepartment of Pathology, University of Miami, Miami, Florida, USA mmartins@med.miami.edu.ORCID https://orcid.org/0000-0001-8336-216X
Damien C TullyRagon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, USA.
Núria Pedreño-LopezDepartment of Pathology, University of Miami, Miami, Florida, USA.
Benjamin von BredowDepartment of Pathology and Laboratory Medicine, University of Wisconsin, Madison, Wisconsin, USA.
Matthias G PauthnerDepartment of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, USA.
Young C ShinDepartment of Pathology, University of Miami, Miami, Florida, USA.
Maoli YuanInternational AIDS Vaccine Initiative, AIDS Vaccine Design and Development Laboratory, Brooklyn, New York, USA.
Noemia S LimaLaboratório de Biologia Molecular de Flavivirus, Instituto Oswaldo Cruz-FIOCRUZ, Rio de Janeiro, Brazil.
David J BeanRagon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, USA.
Lucas Gonzalez-NietoDepartment of Pathology, University of Miami, Miami, Florida, USA.
Aline DominguesDepartment of Pathology, University of Miami, Miami, Florida, USA.
Martin J GutmanDepartment of Pathology, University of Miami, Miami, Florida, USA.
Helen S MaxwellDepartment of Pathology, University of Miami, Miami, Florida, USA.
Diogo M MagnaniDepartment of Pathology, University of Miami, Miami, Florida, USA.
Michael J RicciardiDepartment of Pathology, University of Miami, Miami, Florida, USA.
Varian K BaileyDepartment of Pathology, University of Miami, Miami, Florida, USA.
John D AltmanDepartment of Microbiology and Immunology, Emory University, Atlanta, Georgia, USA.
Dennis R BurtonRagon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, USA.
Keisuke EjimaSchool of Public Health, Indiana University Bloomington, Bloomington, Indiana, USA.
David B AllisonSchool of Public Health, Indiana University Bloomington, Bloomington, Indiana, USA.
David T EvansDepartment of Pathology and Laboratory Medicine, University of Wisconsin, Madison, Wisconsin, USA.
Eva G RakaszWisconsin National Primate Research Center, University of Wisconsin, Madison, Wisconsin, USA.
Christopher L ParksInternational AIDS Vaccine Initiative, AIDS Vaccine Design and Development Laboratory, Brooklyn, New York, USA.
Myrna C BonaldoLaboratório de Biologia Molecular de Flavivirus, Instituto Oswaldo Cruz-FIOCRUZ, Rio de Janeiro, Brazil.
Saverio CapuanoWisconsin National Primate Research Center, University of Wisconsin, Madison, Wisconsin, USA.
Jeffrey D LifsonAIDS and Cancer Virus Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
Ronald C DesrosiersDepartment of Pathology, University of Miami, Miami, Florida, USA.ORCID https://orcid.org/0000-0001-6851-3003
Todd M AllenRagon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, USA.
David I WatkinsDepartment of Pathology, University of Miami, Miami, Florida, USA.
University of Miami · USUniversity of Wisconsin–Madison · USRagon Institute of MGH, MIT and Harvard · USFundação Oswaldo Cruz · BRIndiana University Bloomington · USInternational AIDS Vaccine Initiative · USScripps Research Institute · USEmory University · USLeidos (United States) · US

Funding

WNPRC Supplemental Request for Nonhuman Primate Enclosures to Equip HIV/AIDS-Related Research FacilitiesP51OD011106 · OD · UNIVERSITY OF WISCONSIN-MADISON · PI Dorota A. Grejner-Brzezinska · 2012 to 2026
$150.7M
Vaccine Adjuvant/ Delivery Systems CoreP01AI104715 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI IRVINE, DARRELL J · 2013 to 2017
$12.3M
The Functional Significance of CTL EscapeR37AI052056 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI WATKINS, DAVID I · 2008 to 2017
$7.1M
Sustained antibody delivery for durable suppression of immunodeficiency virus replicationR01AI121135 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI David T Evans · 2015 to 2026
$6.9M
Gamma-2 Herpesviruses as Vaccine Vectors for AIDSR37AI063928 · NIAID · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI DESROSIERS, RONALD C · 2013 to 2022
$5.1M
Can vaccine-induced CD8 T cells prevent chronic phase AIDS virus replication?R01AI108421 · NIAID · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI WATKINS, DAVID I · 2014 to 2018
$2.9M
KIR and MHC Class I Immunogenetics in SIV InfectionR01AI095098 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI EVANS, DAVID T · 2012 to 2016
$2.7M
Lentiviral Resistance to TetherinR01AI098485 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI EVANS, DAVID T · 2012 to 2016
$2.2M
Ipilimumab as an adjuvant for HIV vaccinesK01OD023032 · OD · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI MARTINS, MAURICIO DE AGUIAR · 2016 to 2018
$993k
A Novel, Logical Approach to HIV Vaccine DevelopmentR56AI049120 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI WATKINS, DAVID I · 2011 to 2011
$719k
CCR NIH HHS HHSN261200800001CNCI NIH HHS HHSN261200800001ENIAID NIH HHS P01 AI104715NIAID NIH HHS R01 AI095098NIAID NIH HHS R01 AI098485NIAID NIH HHS R01 AI108421NIAID NIH HHS R01 AI121135NIAID NIH HHS R37 AI052056NIAID NIH HHS R37 AI063928NIAID NIH HHS R56 AI049120NIH HHS K01 OD023032NIH HHS P51 OD011106
6 · The paper itself

Abstract

Certain major histocompatibility complex class I (MHC-I) alleles are associated with spontaneous control of viral replication in human immunodeficiency virus (HIV)-infected people and simian immunodeficiency virus (SIV)-infected rhesus macaques (RMs). These cases of "elite" control of HIV/SIV replication are often immune-mediated, thereby providing a framework for studying anti-lentiviral immunity. In this study, we examined how vaccination impacts SIV replication in RMs expressing the MHC-I allele

Indexed as

AllelesAnimalsAntibodies, NeutralizingAntibodies, ViralGene Products, envGene Products, nefGene Products, vifHistocompatibility Antigens Class IMacaca mulattaSAIDS VaccinesSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusViral LoadViremiaVirus ReplicationAntibodies, NeutralizingAntibodies, ViralGene Products, envGene Products, nefGene Products, vifHistocompatibility Antigens Class ISAIDS VaccinesAIDShuman immunodeficiency virussimian immunodeficiency virusvaccines

Identifiers

PMID29875239
PMCPMC6069176
OpenAlexW2805687301

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.